Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Insights

IBD Drive Time Logo
Podcast
09/05/2023
Dr Edward Loftus reviews details of the pivotal trial where upadacitinib emerged a superior alternative to placebo for induction and maintenance therapy among patients with moderate-to-severe Crohn’s disease.
Dr Edward Loftus reviews details of the pivotal trial where upadacitinib emerged a superior alternative to placebo for induction and maintenance therapy among patients with moderate-to-severe Crohn’s disease.
Dr Edward Loftus reviews details...
09/05/2023
Advances in Inflammatory Bowel Disease Network
Adam Faye, MD, MS
News
08/31/2023
In this podcast, Dr Adam Faye explains the association between various patient-level demographic, nutritional and clinical factors and risk for complications among older patients who underwent intestinal resection for inflammatory bowel...
In this podcast, Dr Adam Faye explains the association between various patient-level demographic, nutritional and clinical factors and risk for complications among older patients who underwent intestinal resection for inflammatory bowel...
In this podcast, Dr Adam Faye...
08/31/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
08/29/2023
Dr Gil Melmed from Cedars-Sinai talks with Drs Raymond Cross and Millie Long about the importance of vaccines, cancer screenings, and other aspects of overall health maintenance for patients with inflammatory bowel disease.
Dr Gil Melmed from Cedars-Sinai talks with Drs Raymond Cross and Millie Long about the importance of vaccines, cancer screenings, and other aspects of overall health maintenance for patients with inflammatory bowel disease.
Dr Gil Melmed from Cedars-Sinai...
08/29/2023
Advances in Inflammatory Bowel Disease Network
Jessica Allegretti
Video
08/18/2023
Dr Allegretti reviews her presentation from the AIBD regional meetings on how to most effectively use existing therapies and apply a treat-to-target approach in managing inflammatory bowel disease.
Dr Allegretti reviews her presentation from the AIBD regional meetings on how to most effectively use existing therapies and apply a treat-to-target approach in managing inflammatory bowel disease.
Dr Allegretti reviews her...
08/18/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
08/14/2023
Guest Christina Ha, MD, from the Mayo Clinic in Arizona, reviews key points about biosimilar therapies, including reassuring patients and countering the "nocebo" effect, with hosts Drs Raymond Cross and Millie Long.
Guest Christina Ha, MD, from the Mayo Clinic in Arizona, reviews key points about biosimilar therapies, including reassuring patients and countering the "nocebo" effect, with hosts Drs Raymond Cross and Millie Long.
Guest Christina Ha, MD, from the...
08/14/2023
Advances in Inflammatory Bowel Disease Network
Noa Cleveland
Video
08/11/2023
In this video, courtesy of the University of Chicago, Dr Noa Krugliak Cleveland demonstrates the use of intestinal ultrasound and Dr David Rubin, chief of gastroenterology, hepatology, and nutrition, discusses the advantages of this advancing...
In this video, courtesy of the University of Chicago, Dr Noa Krugliak Cleveland demonstrates the use of intestinal ultrasound and Dr David Rubin, chief of gastroenterology, hepatology, and nutrition, discusses the advantages of this advancing...
In this video, courtesy of the...
08/11/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
07/28/2023
Dr David Rubin discusses the hurdles of prior authorization and ways to manage the process to ensure patients can receive their IBD therapies with guests David Choi, PharmD, and Mona Shah, MPH.
Dr David Rubin discusses the hurdles of prior authorization and ways to manage the process to ensure patients can receive their IBD therapies with guests David Choi, PharmD, and Mona Shah, MPH.
Dr David Rubin discusses the...
07/28/2023
Advances in Inflammatory Bowel Disease Network
Florian Rieder
Video
07/22/2023
Dr Rieder reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on removing barriers to optimizing treatment for luminal Crohn's disease.
Dr Rieder reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on removing barriers to optimizing treatment for luminal Crohn's disease.
Dr Rieder reviews his...
07/22/2023
Advances in Inflammatory Bowel Disease Network
David Rubin
Video
07/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
07/22/2023
Advances in Inflammatory Bowel Disease Network
Gil Melmed
Conference Coverage
07/22/2023
Dr Melmed evaluates key efficacy and safety data for interleukin -12/23 and -23 inhibitors for the management of IBD from his presentation at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Melmed evaluates key efficacy and safety data for interleukin -12/23 and -23 inhibitors for the management of IBD from his presentation at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Melmed evaluates key efficacy...
07/22/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement